EG.5.1 Covid variant takes off, India not at risk currently

On August 11, India has 1,505 active Covid-19 cases according to the Ministry of Health and Family Welfare  

Phylogenetic tools can help track COVID-19 variants faster. Here's how

Studying the evolutionary path of the virus can help countries assess their vaccine strategy

COVID is surging in the world’s most vaccinated country. Why?

Seychelles needs to conduct urgent genome sequencing and surveillance to see what contribution variants of concern are making and whether the …

COVID-19: Beware of ‘Mexican variant’

Down To Earth speaks to Saumitra Das, director of the National Institute of Biomedical Genomics in West Bengal about the possible role of a …

What’s the new coronavirus variant in India and how should it change their COVID-19 response?

In 15-20% samples from Maharashtra, the state accounting for 62% of cases in the country, a new, double mutation in key areas of the virus has …

Is COVID-19 pandemic nearing its end? Experts weigh in

Whether or not to ‘call off’ a pandemic goes beyond epidemiology of disease    

Health ministry confirms 2 more coronavirus variants in India

Uptick in cases in 5 states cannot be linked to these variants as of now, said NITI Aayog member VK Paul 

Watch: How WHO has relabelled COVID-19 variants

How to read your Alpha, Beta, Kappa the new way

Should we worry about the XE variant? Maybe not yet, but ‘hybrids’ will become more frequent as COVID-19 evolves

XE has a slight transmission advantage over BA.2

WHO lists only one strain of COVID-19 that emerged in India as a variant of concern

WHO had declared a total of three strains found in India variants of concern

New Delta+ variant found in India can escape antibodies

Mutations in the Delta+ variant can render vaccines and treatments ineffective

India reports 21 cases of COVID sub-variant JN.1, now a WHO ‘variant of interest’

We need to be on the alert, but there is no need to panic, says Union Health Minister Mansukh Mandaviya

Dismal figures: ‘India sequenced less than 1% of total COVID-19 samples in nearly 3 months’

Lack of funds, difficulty in getting samples among reasons for poor numbers